Genomics In Cancer Care Market To Reach USD 39.94 Billion By 2027 | Illumina Inc., Cancer Genetics Inc., Sigma Aldrich, and Perkin Elmer, among others. 1
Genomics In Cancer Care Market To Reach USD 39.94 Billion By 2027 | Illumina Inc., Cancer Genetics Inc., Sigma Aldrich, and Perkin Elmer, among others.
Reports And Data
Rising incidence of cancer is one of the significant factors influencing the growth of the genomics in cancer care market. Genomics In Cancer Care Market Size – USD 11.89 Billion in 2019, Market Growth – CAGR of 16.3%, Market Trends –Advancement in technology.

The global genomics in cancer care market is forecasted to reach USD 39.94 Billion by 2027, according to a new report by Reports and Data. The genomics in cancer research market is observing high demand attributed to the rising incidence of cancer. Cancer has a significant impact on society in the U.S. and across the globe. It has been estimated that 1,735,350 new disease cases were diagnosed in the U.S., and 609,640 people suffered death from the disease. The number of new incidences of the disease is 439.2 per 100,000 men and women annually, and the number of cancer-related morbidities is 163.5 per 100,000 men and women annually. Moreover, it has been estimated that in 2017, 15,270 children and adolescents in the age range of 0-19 years were diagnosed with disease, out of which 1,790 suffered death owing to the disease. In the year 2017, an estimated USD 147.30 billion was spent on cancer care in the US.

The COVID-19 impact:

The COVID-19 pandemic has made it essential to repurpose the operating rooms for surgeries into intensive care units (ICUs) and pushed hospitals to accommodate patients beyond their full capacity of beds. As a result, in several cases, cancer patients were categorized as non-urgent. Further, the psychological influence of postponed disease diagnosis as a result of the COVID-19 pandemic cannot be undermined as when psychological, physical, and social health of patients are handled in a positive way, chances of patients’ survival have been seen to improve from a state of illness towards recovering from the disease. COVID-19 has had a significant and negative impact on cancer treatment and research, making a new health emergency for cancer patients’ management a necessity.

Get a Sample Copy of This Report : https://www.reportsanddata.com/sample-enquiry-form/3712

 Further key findings from the report suggest

  • Pharmaceutical companies are making use of the available genomic information in personalized medicine, which is forecasted to significantly impact the growth of the market. The reduction in the cost of sequencing has enabled whole-genome sequencing at a very affordable price, which has made it more attractive to pharmaceutical and biotechnology companies.
  • Genome sequencing held a significant share of genomics in the cancer care market in 2019 due to its adoption of whole-genome sequencing and application of the sequence databases for disease prognosis and screening.
  • Polymerase chain reaction (PCR) has several advantages, which are boosting the demand for genomics in the cancer care market. The reaction is simple, easy to understand, and also produces results quickly. The technique is very sensitive, with the potential to produce billions of copies of a certain product for cloning, sequencing, and analysis. Thus, it finds its use in analyzing alterations of gene expression levels in tumors, microbes, or other disease states.
  • North America contributed to the largest genomics in cancer care market share in 2019. The market dominance is owing to the higher acceptance of advanced technologies, well-established healthcare diagnostic facilities, the surging incidence of cancer, and the enactment of numerous initiatives for raising awareness about the disease in the region.
  • Key participants include Agilent Technologies, Bio-Rad Laboratories, Qiagen, GE Healthcare, Roche Diagnostics, Abbott Laboratories, Illumina Inc., Cancer Genetics Inc., Sigma Aldrich, and Perkin Elmer, among others.

Buy Now: https://www.reportsanddata.com/checkout-form/3712

For the purpose of this report, Reports and Data has segmented into the global genomics in cancer care market on the basis of product type, technology, application, end-user, and region:

Product Type Outlook (Revenue, USD Million; 2017-2027)

  • Instruments
  • Consumables
  • Services

Technology Outlook (Revenue, USD Million; 2017-2027)

  • PCR
  • Genome Sequencing
  • Nucleic Acid Extraction & Purification
  • Microarray
  • Others

Application Outlook (Revenue, USD Million; 2017-2027)

  • Diagnostics
  • Personalized Medicine
  • Drug Discovery & Development
  • Others

End-User Outlook (Revenue, USD Million; 2017-2027)

  • Hospitals
  • Research Institutes
  • Others

Regional Outlook (Revenue, USD Million; 2017-2027)

  • North America
  • Europe
  • Asia Pacific
  • MEA
  • Latin America

To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/genomics-in-cancer-care-market

Table of Content:

Chapter 1.    Market Synopsis

    1.1.    Market Definition

    1.2.    Research Scope & Premise

    1.3.    Methodology

    1.4.    Market Estimation Technique

Chapter 2.    Executive Summary

    2.1.    Summary Snapshot, 2019-2027

Chapter 3.    Indicative Metrics

Chapter 4.    Genomics In Cancer Care Market Segmentation & Impact Analysis

    4.1.    Genomics In Cancer Care Market Material Segmentation Analysis

    4.2.    Industrial Outlook

           4.2.1.    Market indicators analysis

           4.2.2.    Market drivers analysis

                   4.2.2.1.    Rising incidence of cancer

                   4.2.2.2.    Increasing awareness about early disease diagnosis

                   4.2.2.3.    Growing geriatric population

                   4.2.2.4.    Advancement in Technology

           4.2.3.    Market restraints analysis

                    4.2.3.1.    Cost prohibitive genomic equipment

    4.3.    Technological Insights

    4.4.    Regulatory Framework

    4.5.    ETOP Analysis

    4.6.    Porter’s Five Forces Analysis

    4.7.    Competitive Metric Space Analysis

    4.8.    Price trend Analysis

    4.9.    Customer Mapping

    4.10.    Covid-19 Impact Analysis

    4.11.    Global Recession Influence

Chapter 5.    Genomics In Cancer Care Market By Product Type Insights & Trends

    5.1.    Product Type Dynamics & Market Share, 2019 & 2027

    5.2.    Instrument

          5.2.1.    Market estimates and forecast, 2017 – 2027  (USD Million)

          5.2.2.    Market estimates and forecast, By Region, 2017 – 2027  (USD Million)

    5.3.    Consumables

          5.3.1.    Market estimates and forecast, 2017 – 2027  (USD Million)

          5.3.2.    Market estimates and forecast, By Region, 2017 – 2027  (USD Million)

    5.4.    Services

          5.4.1.    Market estimates and forecast, 2017 – 2027  (USD Million)

          5.4.2.    Market estimates and forecast, By Region, 2017 – 2027  (USD Million)

Chapter 6.    Genomics In Cancer Care Market By Technology Insights & Trends

    6.1.    Technology Dynamics & Market Share, 2019 & 2027

    6.2.    PCR

         6.2.1.    Market estimates and forecast, 2017 – 2027  (USD Million)

         6.2.2.    Market estimates and forecast, By Region, 2017 – 2027  (USD Million)

    6.3.    Genome Sequencing

          6.3.1.    Market estimates and forecast, 2017 – 2027  (USD Million)

          6.3.2.    Market estimates and forecast, By Region, 2017 – 2027  (USD Million)

    6.4.    Nucleic Acid Extraction & Purification

          6.4.1.    Market estimates and forecast, 2017 – 2027  (USD Million)

          6.4.2.    Market estimates and forecast, By Region, 2017 – 2027  (USD Million)

    6.5.    Microarray

          6.5.1.    Market estimates and forecast, 2017 – 2027  (USD Million)

          6.5.2.    Market estimates and forecast, By Region, 2017 – 2027  (USD Million)

    6.6.    Others

          6.6.1.    Market estimates and forecast, 2017 – 2027  (USD Million)

          6.6.2.    Market estimates and forecast, By Region, 2017 – 2027  (USD Million)

Chapter 7.    Genomics In Cancer Care Market By Application Insights & Trends

    7.1.    Application Dynamics & Market Share, 2019 & 2027

    7.2.    Diagnostics

          7.2.1.    Market estimates and forecast, 2017 – 2027  (USD Million)

          7.2.2.    Market estimates and forecast, By Region, 2017 – 2027  (USD Million)

    7.3.    Personalized Medicine

          7.3.1.    Market estimates and forecast, 2017 – 2027  (USD Million)

          7.3.2.    Market estimates and forecast, By Region, 2017 – 2027  (USD Million)

    7.4.    Drug Discovery & Development

           7.4.1.    Market estimates and forecast, 2017 – 2027  (USD Million)

           7.4.2.    Market estimates and forecast, By Region, 2017 – 2027  (USD Million)

    7.5.    Research

          7.5.1.    Market estimates and forecast, 2017 – 2027  (USD Million)

          7.5.2.    Market estimates and forecast, By Region, 2017 – 2027  (USD Million)

Chapter 8.    Genomics In Cancer Care Market By End-User Insights & Trends

    8.1.    End-User Dynamics & Market Share, 2019 & 2027

    8.2.    Hospitals

          8.2.1.    Market estimates and forecast, 2017 – 2027  (USD Million)

          8.2.2.    Market estimates and forecast, By Region, 2017 – 2027  (USD Million)

    8.3.    Research Institutes

          8.3.1.    Market estimates and forecast, 2017 – 2027  (USD Million)

          8.3.2.    Market estimates and forecast, By Region, 2017 – 2027  (USD Million)

    8.4.    Others

          8.4.1.    Market estimates and forecast, 2017 – 2027  (USD Million)

          8.4.2.    Market estimates and forecast, By Region, 2017 – 2027  (USD Million)

Chapter 9.    Genomics In Cancer Care Market Regional Outlook

Chapter 11.     Company Profiles                   

    11.1.    Agilent Technologies

           11.1.1.    Company Overview

           11.1.2.    Financial Performance

           11.1.3.    Technology Insights

            11.1.4.    Strategic Initiatives

    11.2.    Bio-Rad Laboratories

            11.2.1.    Company Overview

            11.2.2.    Financial Performance

            11.2.3.    Technology Insights

            11.2.4.    Strategic Initiatives

    11.3.    Qiagen

            11.3.1.    Company Overview

            11.3.2.    Financial Performance

            11.3.3.    Technology Insights

            11.3.4.    Strategic Initiatives

Continue…

About Us:

Our in-house experts assist our clients with advice based on their proficiency in the market that helps them in creating a compendious database for the clients. Our team offers expert insights to clients to guide them through their business ventures. We put in rigorous efforts to keep our clientele satisfied and focus on fulfilling their demands to make sure that the end-product is what they desire. We excel in diverse fields of the market and with our services extending to competitive analysis, research and 

Media Contact
Company Name: Reports and Data
Contact Person: John Watson
Email: Send Email
Phone: +1-212-710-1370
Address:40 Wall St. 28th floor
City: New York City
State: NY 10005
Country: United States
Website: https://www.reportsanddata.com/press-release/global-genomics-in-cancer-care-market